|
Health policy and outcome research
Citations 531-540 of 644 total displayed.
|
Past content
(since Jan 1999):
|
- Correspondence
Combining Composite Endpoints: Counterintuitive or a Mathematical Impossibility? • Response
- Kenneth M. Kessler, David L. DeMets, and Robert M. Califf
Circulation 2003;107:e70, doi:10.1161/01.CIR.0000057824.54126.67
[Full text]
- Clinical Investigations and Reports
Twenty-Year Survival After Coronary Artery Surgery: An Institutional Perspective From Emory University
- William S. Weintraub, Stephen D. Clements, Jr, L. Van-Thomas Crisco, Robert A. Guyton, Joseph M. Craver, Ellis L. Jones, and Charles R. Hatcher, Jr
Circulation 2003;107:1271-1277; published online before print as doi:10.1161/01.CIR.0000053642.34528.D9
[Abstract]
[Full text]
- Clinical Investigations and Reports
Cost Implications of the Use of Ramipril in High-Risk Patients Based on the Heart Outcomes Prevention Evaluation (HOPE) Study
- Andre Lamy, Salim Yusuf, Janice Pogue, Amiram Gafni on Behalf of the HOPE Investigators*
Circulation 2003;107:960-965; published online before print as doi:10.1161/01.CIR.0000050600.49419.25
[Abstract]
[Full text]
- Articles
Twenty-Year Survival After Coronary Artery Surgery. An Institutional Perspective From Emory University
- William S. Weintraub, Stephen D. Clements, Jr, L. Van-Thomas Crisco, Robert A. Guyton, Joseph M. Craver, Ellis L. Jones, and Charles R. Hatcher, Jr
Circulation published February 17, 2003, doi:10.1161/01.CIR.0000053642.34528.D9
[Abstract]
- AHA Scientific Statements
American Heart Association Guide for Improving Cardiovascular Health at the Community Level: A Statement for Public Health Practitioners, Healthcare Providers, and Health Policy Makers From the American Heart Association Expert Panel on Population and Prevention Science
- Thomas A. Pearson, Terry L. Bazzarre, Stephen R. Daniels, Joan M. Fair, Stephen P. Fortmann, Barry A. Franklin, Larry B. Goldstein, Yuling Hong, George A. Mensah, James F. Sallis, Jr, Sidney Smith, Jr, Neil J. Stone, and Kathryn A. Taubert
Circulation 2003;107:645-651, doi:10.1161/01.CIR.0000054482.38437.13
[Full text]
- Articles
Cost Implications of the Use of Ramipril in High-Risk Patients Based on the Heart Outcomes Prevention Evaluation (HOPE) Study
- Andre Lamy, Salim Yusuf, Janice Pogue, Amiram Gafni on Behalf of the HOPE Investigators
Circulation published February 3, 2003, doi:10.1161/01.CIR.0000050600.49419.25
[Abstract]
- Brief Rapid Communications
Should Volume Standards for Cardiovascular Surgery Focus Only on High-Risk Patients?
- Philip P. Goodney, F.L. Lucas, and John D. Birkmeyer
Circulation 2003;107:384-387; published online before print as doi:10.1161/01.CIR.0000051721.60127.EA
[Abstract]
[Full text]
- Special Review: Clinical Cardiology: New Frontiers
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises: Part I: Aging Arteries: A "Set Up" for Vascular Disease
- Edward G. Lakatta and Daniel Levy
Circulation 2003;107:139-146, doi:10.1161/01.CIR.0000048892.83521.58
[Full text]
- Brief Rapid Communications
Should Volume Standards for Cardiovascular Surgery Focus Only on High-Risk Patients?
- Philip P. Goodney, F. L. Lucas, and John D. Birkmeyer
Circulation published December 30, 2002, doi:10.1161/01.CIR.0000051721.60127.EA
[Abstract]
- AHA Special Reports
Task Force on Strategic Research Direction: Basic Science Subgroup Key Science Topics Report
- Joseph Loscalzo, Robert Balaban, Lance B. Becker, Geoffrey S. Ginsburg, Vladimir C. Hachinski, John E. Hall, Donald D. Heistad, Leslie A. Leinwand, Claude J. Lenfant, Eduardo Marban, Eric N. Olson, and Stephen M. Schwartz
Circulation 2002;106:e149-161e, doi:10.1161/01.CIR.0000040842.08331.4E
[Full text]
|
|
